Statements of Cash Flows - USD ($)	1 Months Ended	11 Months Ended	12 Months Ended
	Dec. 31, 2014	Nov. 20, 2014	Dec. 31, 2015
Successor [Member]
Cash flows from Operating Activities
Net income (loss)	$ (70,155)		$ (521,874)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	3,026		19,772
Changes in operating assets and liabilities:
Prepaid expense and other current assets	7,181		(1,272)
Accounts payable and accrued expenses	6,343		(8,609)
Accrued interest – related parties	563		1,143
Accounts payable – related party			144,426
Net cash used in operating activities	(53,042)		(366,414)
Cash flows from Investing Activities
Investment in patents	(2,769)		(4,497)
Capital expenditures			(7,081)
Net cash used in investing activities	(2,769)		(11,578)
Cash flows from Financing Activities
Premium received from stock subscription			80,574
Net cash provided by financing activities			80,574
Net change in cash	(55,811)		(297,418)
Cash and cash equivalents at beginning of period	374,367		318,556
Cash and cash equivalents at end of period	318,556	$ 374,367	21,138
Supplemental Cash Flow Information
Cash paid for interest			910
Cash paid for income taxes	0		$ 0
Predecessor [Member]
Cash flows from Operating Activities
Net income (loss)		2,909,870
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization		14,515
Debt Forgiveness Income		(3,422,850)
Changes in operating assets and liabilities:
Prepaid expense and other current assets		37,890
Accounts payable and accrued expenses		21,342
Accrued interest – related parties		(62,706)
Net cash used in operating activities		(501,939)
Cash flows from Investing Activities
Investment in patents		(7,830)
Net cash used in investing activities		(7,830)
Cash flows from Financing Activities
Proceeds from notes payable related party		1,010,392
Payments on notes payable related party		(132,795)
Net cash provided by financing activities		877,597
Net change in cash		367,828
Cash and cash equivalents at beginning of period	$ 374,367	6,539
Cash and cash equivalents at end of period		374,367
Supplemental Cash Flow Information
Cash paid for interest		62,993
Non-Cash Transactions
Conversion of related party notes payable to common stock		1,941,211
Conversion of preferred stock to common stock		$ 1,717